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This paper describes a gradient-generating microfluidic platform for optimizing proliferation and
differentiation of neural stem cells (NSCs) in culture. Microfluidic technology has great potential
to improve stem cell (SC) cultures, whose promise in cell–based therapies is limited by the inability
to precisely control their behavior in culture. Compared to traditional culture tools, microfluidic
platforms should provide much greater control over cell microenvironment and rapid
optimization of media composition using relatively small numbers of cells. Our platform exposes
cells to a concentration gradient of growth factors under continuous flow, thus minimizing
autocrine and paracrine signaling. Human NSCs (hNSCs) from the developing cerebral cortex
were cultured for more than 1 week in the microfluidic device while constantly exposed to a
continuous gradient of a growth factor (GF) mixture containing epidermal growth factor (EGF),
fibroblast growth factor 2 (FGF2) and platelet-derived growth factor (PDGF). Proliferation and
differentiation of NSCs into astrocytes were monitored by time-lapse microscopy and
immunocytochemistry. The NSCs remained healthy throughout the entire culture period, and
importantly, proliferated and differentiated in a graded and proportional fashion that varied
directly with GF concentration. These concentration-dependent cellular responses were
quantitatively similar to those measured in control chambers built into the device and in parallel
cultures using traditional 6-well plates. This gradient-generating microfluidic platform should be
useful for a wide range of basic and applied studies on cultured cells, including SCs.
Introduction
Stem cells (SCs) hold tremendous promise for fundamental
biological studies and cell-based therapies in human
disorders.1–4 Among other advantages, SCs can be expanded
in culture, genetically modified using existing gene delivery
tools, and differentiated into cell types needed for cell
replacement or tissue engineering.3–5 SCs therefore provide a
multipronged approach to potential cell-based therapies.3,4,6
The promise of SCs holds true for tissue-specific SCs as well,
such as neural stem cells (NSCs).5 NSCs are defined as cells
that can self-renew yet maintain the ability to generate the
three principal cell types of the central nervous system
(CNS)—neurons, astrocytes, and oligodendrocytes.6–8 NSCs
therefore have therapeutic possibilities in multiple neuro-
developmental and neurodegenerative diseases, such as
Alzheimer’s and Parkinson’s diseases,3,4,9 for which effective
therapies are limited or lacking.
Unfortunately, several concerns with SC cultures currently
limit their therapeutic promise.3 One major problem is the
inability to precisely control SC behavior in culture, such
as their proliferation and specification into different cell
types.10,11 Conventional cell culture technology is ill-suited to
tackle this problem. For example, precise and thorough com-
binatorial studies with multiple growth factors are technically
infeasible using traditional cultures, and traditional cultures
require relatively large volumes of media and correspondingly
large amounts of costly growth factors and other reagents.12,13
Microfluidic cell cultures have the potential to overcome
some of the problems imposed by traditional culture tools.12,13
Advances in soft lithography and microfluidics have enabled
the development of microfluidic devices for cell-based applica-
tions.12,14 We have previously reported microfluidic chemo-
taxis chambers15,16 that can generate precise concentration
mixtures and allow real-time observation of migrating cells.
This approach was used to investigate chemotaxis of neutrophils
in chemokine (Interleukin-8) gradients15 and metastatic breast
cancer cells in epidermal growth factor (EGF) gradients.16 Due
to their biocompatibility, poly(dimethylsiloxane) (PDMS)
microfluidic devices are increasingly used as microscale incu-
bators to culture a variety of cells for days to weeks.17–20
This paper describes an experimental platform for optimiz-
ing proliferation and differentiation conditions for NSCs using
a gradient-generating microfluidic device.21,22 In this device,
we cultured human NSCs (hNSCs) isolated from the develop-
ing cerebral cortex in a continuous concentration gradient of
known growth factors. These cells exhibited proliferation and
differentiation responses that were concentration-dependent
and quantitatively similar to those seen in parallel control
cultures.
{ Electronic supplementary information (ESI) available: Time lapse
movie of gradient chamber. Fig. S1, Tables S1 and S2. See http://
www.rsc.org/suppdata/lc/b4/b417651k/
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Experimental
Fabrication of the microfluidic device
The microfluidic NSC culture device was fabricated in PDMS
using rapid prototyping and soft lithography following
published procedures.15,21,23–26 The master mold was fabri-
cated by patterning 100 mm thick negative photoresist (SU8 50,
Microchem, MA) by photolithography.22 A positive replica
with an embossed network of microchannels was fabricated by
replica molding PDMS against the master.21,23–25 The surface
of PDMS and glass slide were activated with reactive oxygen
plasma (2 min at 30W, model PDC-001, Harrick Scientific,
NY) and brought together immediately to form an irreversible
seal.15,22 The PDMS was attached to the glass slide such that
glass forms the bottom of the channels and provides a surface
for cellular adhesion. The cell culture area (near the outlet,
2.4 mm wide channel in gradient devices) was covered with a
glass slide during plasma treatment to prevent permanent
bonding. This step allowed removal of PDMS portion around
the cell culture area for immunocytochemistry and fluores-
cence microscopy. After assembly, the device surface was
coated with poly-L-lysine (PLL; 0.5 mg mL21 in 0.1 M borate
buffer at room temperature for 1 h)30,31 and mouse laminin
(0.5 mg mL21 at 37 uC for 8 h). Microfluidic devices were
connected to syringe pumps with base medium (left 2 inlets) or
base medium with growth factors (right inlet) to generate a
spatial concentration gradient (combinatorial mixture) of the
growth factors perpendicular to the channel across the cell
culture area.15,22 The stability and shape of the soluble growth
factor gradient was confirmed by imaging fluorescence from
fluorescein isothiocyanate (FITC)–dextran. FITC–dextran
(10 mM, MW 10,000), which has a similar molecular weight
to growth factors like EGF (MW 6,000), was added to the
growth factor-containing media to serve as an indirect
indicator of the growth factor gradient inside the channel.16
The observed gradient profile matched the mathematical
prediction as in previous work.21,22
Human NSC (hNSC)
The hNSCs isolated from the developing cerebral cortex of
premature human infants1,2 (SC23) were provided by the
National Human Neural Stem Cell Resource at the Children’s
Hospital of Orange County, and grown as adherent cultures in
fibronectin-coated flasks in a humidified incubator at 37 uC
with 5% CO2. Cells were cultured in base medium consisting of
Dulbecco’s modified Eagle’s medium: F12 nutrient mixtures
(DMEM:F12, Invitrogen, CA) supplemented with 20% BIT
9500 (Stem Cell Technologies, Canada) and 1% antibiotic/
antimycotic (Invitrogen, CA).1,2 Growth medium was pre-
pared from base medium by adding three human recombinant
growth factors, each at 40 ng mL21: epidermal growth factor
(EGF, BD Biosciences, MA), fibroblast growth factor 2
(FGF2, BD Biosciences, MA), and platelet-derived growth
factor (PDGF, PeproTech, NJ).1,2
Microfluidic cultures and time-lapse microscopy
The hNSCs were detached from the culture flask using
Cell Dissociation Buffer (Invitrogen, CA), washed, and
resuspended in culture medium. Cells (100 mL suspension of
500,000 cells mL21) were loaded into the microfluidic device
via cell inlet ports on sides of the chambers using a micro-
pipette tip. The microfluidic device containing adherent
hNSCs was placed inside an environmental chamber (37 uC
and 5% CO2 ) on an inverted microscope (Nikon, NY) (see
ESI Fig. S1{ for a picture of the experimental setup). The
microfluidic chamber was maintained with a constant perfu-
sion of media at physiologic pH. Polyethylene tubing was
inserted into three inlets at the top of the gradient chamber to
make fluidic connections.15 The media with and without GF
were injected into the gradient chamber using a syringe pump
at a controlled rate of 0.1 mL min21. Cells cultured inside
microfluidic gradient chambers were thus exposed to a GF
gradient in a stable microenvironment. A motorized stage was
used to obtain images at multiple positions in the microfluidic
device at 10 min intervals.
Immunocytochemistry
After culturing the cells inside microfluidic devices for 7 days,
they were fixed in 4% paraformaldehyde (Sigma, MO) and
permeabilized with 0.3% Triton X-100 in phosphate buffered
saline (PBS, Invitrogen, CA). After washing with PBS, cells
were blocked with 5% bovine serum albumin (BSA, Sigma,
MO) in PBS and sequentially exposed to primary and
secondary antibodies: anti-glial fibrillary acidic protein
(GFAP, Chemicon International, CA; overnight at 4 uC) and
FITC-conjugated AffiniPure donkey anti-rabbit immunoglo-
bulin G (IgG) (Jackson ImmunoResearch Laboratories Inc,
PA; 2 h at room temperature). Cell nuclei were then counter-
stained with Hoechst 33342 (Molecular Probes, OR) and
devices mounted with Vectashield mounting medium (Vector
Laboratories Inc, CA). Immunostained cells were kept at
4 uC until analyzed. Fluorescent images were obtained with
a Nikon E800 upright microscope using a chroma standard
filter (350 nm) for DAPI/Hoechst and a chroma high Q filter
(480 nm) for FITC.
Results and discussion
Design and validation of the gradient-generating device
The device is made up of two types of chambers, a gradient
chamber and two control chambers. The first chamber is
composed of two parts: (1) the gradient-generating micro-
channel network15 (‘‘Christmas tree’’), which utilizes laminar
flow and diffusive mixing to generate a continuous combina-
torial mixture of soluble factors20,26,29 and (2) the cell culture
area near the bottom of the device across which the gradient is
applied. Two control cell culture chambers are also fabricated
next to the main gradient chamber for positive and negative
controls (100% +GF and 2GF).
The gradient chamber network is supplied with media via
three separate inlets from the top of the device (Fig. 1A). The
shape of gradient produced can be controlled by adjusting
the concentration of solutions for the three inlets.15,21,22
For this experiment, we generated a polynomial gradient
(y 5 ax2 + b) by loading the first two inlets with media lacking
growth factors (0%, ‘‘2GF’’ in Fig. 1A) and the third inlet
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with media containing the full complement of GFs (100%,
‘‘+GF’’ in Fig. 1A).22,32 In order to confirm the generation
of a gradient with this device, we placed a solution of
FITC–dextran in the third inlet and solutions without
FITC–dextran in the first two inlets. Using computer
controlled-syringe pumps, we were able to generate a gradient
of fluorescence with micron-scale spatial resolution across the
chamber (Fig. 1B). The GFs (EGF, FGF2, PDGF) used have
similar molecular weights to FITC–dextran, making it likely
that the GF gradient is the same as the observed fluorescence
gradient from FITC–dextran (Fig. 1B).
Human NSCs in control chambers
The control chambers are 500 mm wide and 100 mm high; the
gradient chamber is 2.4 mm wide and 100 mm high with two
barriers at 0.8 mm intervals to limit cell migration across the
width of the chamber. Both the control and gradient chambers
have outlet ports for fluid exit. Since fluid is pumped into the
device at a controlled rate of 0.1 mL min21, the cells in the
gradient chamber would be theoretically subjected to minimal
fluid shear stress on the order of 5 6 1024 dyne cm22 (channel
dimension of 2.4 mm 6 10 mm 6 0.1 mm). This is signifi-
cantly lower than physiological shear stress experienced by
endothelial cells during normal blood flow (y2 dyne cm22).33
In addition, smaller volumes of solutions were sufficient for
long term experiments compared to conventional methods
(y1 mL solution per syringe was adequate for a week-long
experiment with constant perfusion).
We then tested whether hNSCs could be successfully
cultured in the microfluidic device under continuous fluid
flow. The chambers were first precoated with PLL/laminin to
encourage cell adhesion. Dissociated hNSCs were plated into
control chambers at a density of 5 6 105 cells mL21, allowed
to adhere, then exposed to media with or without EGF, FGF2,
and PDGF.1,2 These cells are known to proliferate in the
presence of these GFs and differentiate in their absence.2,27,28
Images taken immediately after plating show that the cells
were well adhered and evenly distributed across the chambers,
but not yet elongated (Fig. 2A, C). After 7 days, cells in media
lacking GFs were elongated and had extended processes, but
showed little proliferation, with comparable cell numbers at
day 7 compared to day 1 (Fig. 2B). Cells in media with GFs
were also elongated after 7 days, but showed a striking increase
in cell number (Fig. 2D). Cell numbers in the control chambers
under flow were occasionally lower than those in conventional
culture dishes lacking fluid flow (Fig. 2E, F). This would be
consistent with the removal of proliferative autocrine and
paracrine factors in the control microfluidic chambers, but not
in the traditional cultures. These studies showed that hNSCs
could be loaded evenly in the chamber, adhered and elongated
along the surface, remained healthy for at least one week under
fluidic flow, and proliferated in response to mitogenic GFs.
Moreover, the cells in microfluidic chambers behaved similarly
to those in conventional culture dishes.
Human NSC proliferation in the gradient chamber
We then cultured cells in the gradient chamber of the micro-
fluidic device. The gradient chamber had two barriers that
limited cell migration and divided the continuous GF gradient
into three compartments with low, intermediate, or high con-
centrations of GFs; 0–2.8 ng mL21 (0–7%), 3.2–14 ng mL21
(8–35%), and 14.4–40 ng mL21 (36–100%) for each GF.
Fig. 1 (A) Schematic design of the microfluidic device showing the
gradient chamber and two control chambers. Cells were loaded into
the chambers via inlet ports, and the entire device was placed on an
inverted microscope for live-cell imaging. (B) The gradient profile
generated within the gradient chamber was visualized with the
fluorescence profile of FITC–dextran.
Fig. 2 Proliferation of hNSCs in control microfluidic chambers.
Phase contrast images show cells in control chambers (A–D) or on
traditional coverslips (E, F). Cells in the chambers were grown in fluid
flow conditions using media with (+GF) or without (2GF) growth
factors. Cells on coverslips in conventional cultures were grown in the
same media for 7 days.
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Soon after plating (on day 1), the cells had adhered to the glass
surface, but were fairly sparse in all three compartments
(Fig. 3A). After 4 days, the cells had elongated and undergone
limited proliferation in the low GF compartment, some
proliferation in the intermediate GF compartment, and more
proliferation in the high GF compartment (Fig. 3B). This
trend continued through day 7, when many more cells were
evident in the high GF compartment (see ESI{ for time-lapse
movies). In addition to the effects on cell proliferation, the GF
gradient within the intermediate and high GF compartments
stimulated cell migration towards the higher GF concentra-
tions (e.g. Fig. 3B and time-lapse movies in ESI{).
Quantification of total cell numbers revealed that the
hNSCs proliferated in direct proportion to the GF concentra-
tion. The hNSCs plated in the control chamber without GFs
showed no cell number increase at 4 or 7 days (Fig. 4A).
However, cells in the low GF compartment of the gradient
chamber (0–2.8 ng mL21 each GF) showed a 1.8-fold increase
at 4 days and a 2.6-fold increase by day 7 (Fig. 4B). Cells in the
intermediate GF compartment (3.2–14 ng mL21) showed a
2.5-fold increase on day 4 and 3.5-fold increase on day 7, while
cell numbers in the high GF compartment (14.4–40 ng mL21)
increased by 3.5-fold and 5-fold at 4 and 7 days, respectively
(Fig. 4B). The control chamber with 100% GF concentration
showed increases of 4-fold on day 4 and 6.8-fold on day 7
(Fig. 4A). We then subdivided each compartment arbitrarily
into 8 equal bins (100 mm wide, Fig. 3B) and reanalyzed the
data. As shown in Fig. 4C, we continued to find a strong
correlation between cell number and GF concentration in all
three compartments (Fig. 4C and data not shown; ESI
Table S1{ for p values), despite the cell migration observed.
Therefore, by culturing hNSCs under a continuous gradient of
GFs, we showed that these cells respond in direct proportion
to GF concentration, at least within the 0–40 ng mL21 range
for EGF, FGF2 and PDGF, and that there is no threshold
or ‘‘all-or-none’’ proliferation response in this concentration
range.
Differentiation of human NSCs into astrocytes in the gradient
chamber
Since GF concentration directed hNSC proliferation, we tested
whether the GF gradient also regulated their differentiation.2
Cells grown for one week in the GF gradient were fixed and
Fig. 3 Proliferation of hNSCs in the gradient chamber. Phase
contrast images show cells cultured for up to 7 days in the gradient
chamber. The concentration gradient is continuous across the entire
chamber, which is divided into three compartments by physical
barriers to limit migration. By the end of the culture period, cell
numbers were greatest in the high GF compartment (36–100% GF)
and lowest in the low GF compartment (0–7% GF). Dashed lines
delineate the 8 equal bins used for quantification in Figs. 4C and 6C.
Fig. 4 Quantitative analysis of hNSC proliferation in the control (A)
or gradient chambers (B, C) at 4 and 7 days. The three compartments
of the gradient chamber are termed low, intermediate, and high. The
fold increase in cell number represents cell numbers on day 4 or 7
divided by initial cell number on day 1. Note that cell numbers are
directly proportional to GF concentration in each gradient compart-
ment. Each bar represents the average for 3 independent experiments
with standard errors of the mean (*p , 0.05, **p , 0.01). Quantitation
within the subdivided intermediate GF compartment shows a strong
positive correlation between cell number and GF concentration
(C; ESI Table S1{ for p values).
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stained with antibodies to astrocytes, one of the main cell types
that differentiate from hNSCs. Cells in the low GF compart-
ment showed increased astrocyte differentiation compared to
cells in the high GF compartment (Fig. 5B). This pattern was
similar to that of cells on coverslips in parallel conventional
culture experiments (Fig. 5C, D). Importantly, the percentage
of astrocytes across the three GF compartments in the gradient
chamber decreased with increasing GF concentration (Fig. 6).
Astrocyte percentages in the gradient chamber were consistent
with those seen in the control microfluidic chambers and on
the coverslips in conventional cultures. We further analyzed
the data after subdividing each compartment into 8 equal
bins, as done to analyze total cell numbers. We continued to
find strong correlations between astrocyte percentage and
GF concentration in all three compartments (Fig. 6C and
data not shown; ESI Table S2{ for p values). Thus, astrocyte
differentiation was inversely proportional to GF concentra-
tion, while proliferation was directly proportional. Like the
proliferation effect, no threshold response in astrocyte
differentiation was seen at the population level over the GF
concentrations used in these experiments.
Conclusions
These results show that hNSCs can be cultured in a micro-
fluidic device under constant fluid flow for more than 1 week
using minimal reagents (y1 mL media per syringe) and
without any detectable detrimental effects on cell adhesion,
proliferation, or differentiation. By applying a continuous
gradient of known GFs across the cells, opposing effects
on proliferation and astrocyte differentiation could be
induced, both of which were graded and proportional to GF
concentration. Neither threshold effects nor plateaus in
proliferation or differentiation responses were detected at the
population level in the GF concentration ranges used. Rather
than requiring multiple independent traditional cultures using
fixed GF concentrations, the microfluidic culture device
allowed these graded responses to be induced and quantified
within a single culture chamber. Additional advantages of this
microfluidic platform over traditional cultures—such as the
minimization of autocrine and paracrine signals, the ability to
Fig. 5 Differentiation of hNSCs into astrocytes in the gradient
chamber. The hNSCs cultured in the gradient chamber (A, B) or
on coverslips (0% GF in C, 100% GF in D) for 7 days exhibit
differentiation into astrocytes (stained by antibody against GFAP,
green). Phase contrast images (A) and fluorescence micrographs
(B, C, D) showing stained nuclei (Hoechst, blue) identify all cells in
the field. Note the significantly higher proportion of astrocytes in the
low GF compartment compared to the other two compartments (B).
Fig. 6 Quantitation of astrocytes in the control (A) and gradient
chambers (B, C) after 7 days. Astrocytes are expressed as a percentage
of the total number of Hoechst-stained cells. Note that astrocyte
percentage is inversely proportional to GF concentration in the
gradient chamber. Each bar indicates the average for 3 independent
experiments with standard errors of the mean (**p , 0.01). The strong
negative correlation between astrocyte percentage and GF concentra-
tion persists after subdividing the intermediate GF compartment into
8 bins (C; ESI Table S2{ for p values).
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apply multiple gradients simultaneously, the ability to micro-
pattern the cell culture surface area, and the low media and cell
requirements—should enable the optimization and control of
hNSC and other SCs in culture prior to use in transplantation
and tissue engineering protocols.
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